Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine (Q65539322)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine |
clinical trial |
Statements
Subcutaneous Campath-1H in Fludarabine-Refractory CLL (English)
0 references
September 2002
0 references
18 year
0 references
65 year
0 references